Dr. Nicole C. Schmitt, MD, FACS
Claim this profileWinship Cancer Institute at Emory University
Studies Cancer
Studies Skin Cancer
5 reported clinical trials
9 drugs studied
Area of expertise
1Cancer
Stage IV
Stage III
2Skin Cancer
Stage IV
Stage III
Affiliated Hospitals
Clinical Trials Nicole C. Schmitt, MD, FACS is currently running
ONC-392 + Pembrolizumab
for Non-Small Cell Lung Cancer
This trial tests ONC-392, an antibody that helps the immune system fight cancer, in patients with advanced or spreading tumors who haven't responded to other treatments. It works by blocking a protein that usually keeps immune responses in check, making it easier for the body to attack cancer cells.
Recruiting1 award Phase 1 & 212 criteria
Atorvastatin
for Hearing Loss in Head and Neck Cancer
Background: Cisplatin is used to treat head and neck cancer. People who take this drug are at risk for hearing loss. Atorvastatin is a drug used to treat high cholesterol. It might reduce the risk of cisplatin-induced hearing loss. Objective: To find out if atorvastatin reduces hearing loss in people treated with cisplatin and radiation. Eligibility: People ages 18 and older with squamous cell carcinoma of the head and neck who will undergo treatment with cisplatin-based chemotherapy and radiation Design: Participants will be screened with their medical records. Participants currently taking a cholesterol-lowering statin medication are invited to participate in the observational arm of the study. Those not taking such a medication are invited to participate in the interventional arm of the study. All participants will have 3 study visits for the purpose of evaluating hearing. One before starting cisplatin treatment, one within 3 months of completing cancer treatment, and one within 2 years of completing cancer treatment. They will have tympanograms. A small flexible tip will be placed in the ear canal. A puff of air will be delivered to assess mobility of the ear drum. They will have hearing tests. They will wear headphones. They will listen to tones that vary in loudness. They will be asked to indicate when they hear a sound. They will complete 3 questionnaires at the time of each hearing test. Participants will have 2 visits for blood tests. These will occur upon consent and 12 weeks after. They will be randomly assigned to take the study drug or placebo orally, once daily. They will take it during cisplatin treatment and for 3 months after treatment. Long-term follow up will include a chart review 2 years after participants complete their cisplatin therapy.
Recruiting0 awards Phase 28 criteria
More about Nicole C. Schmitt, MD, FACS
Clinical Trial Related4 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Nicole C. Schmitt, MD, FACS has experience with
- Pembrolizumab
- Lovastatin
- Audiometric Test
- Cisplatin
- Atorvastatin
- Placebo
Breakdown of trials Nicole C. Schmitt, MD, FACS has run
Cancer
Skin Cancer
Head and Neck Squamous Cell Carcinoma
Throat Cancer
Laryngeal Squamous Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Nicole C. Schmitt, MD, FACS specialize in?
Nicole C. Schmitt, MD, FACS focuses on Cancer and Skin Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is Nicole C. Schmitt, MD, FACS currently recruiting for clinical trials?
Yes, Nicole C. Schmitt, MD, FACS is currently recruiting for 3 clinical trials in Atlanta Georgia. If you're interested in participating, you should apply.
Are there any treatments that Nicole C. Schmitt, MD, FACS has studied deeply?
Yes, Nicole C. Schmitt, MD, FACS has studied treatments such as Pembrolizumab, Lovastatin, Audiometric Test.
What is the best way to schedule an appointment with Nicole C. Schmitt, MD, FACS?
Apply for one of the trials that Nicole C. Schmitt, MD, FACS is conducting.
What is the office address of Nicole C. Schmitt, MD, FACS?
The office of Nicole C. Schmitt, MD, FACS is located at: Winship Cancer Institute at Emory University, Atlanta, Georgia 30322 United States. This is the address for their practice at the Winship Cancer Institute at Emory University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.